Alpha-linolenic acid: A promising nutraceutical for the prevention of stroke

PharmaNutrition

Volumn 1, Issue 1, 2013, Pages 1-8

  Nguemeni, Carine ^a,b   Gouix, Elsa ^a,b   Bourourou, Miled ^a,b   Heurteaux, Catherine ^a,b   Blondeau, Nicolas ^a,b  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Alpha linolenic acid; Enriched diet; Ischemic stroke; Neuroprotection; Nutraceutical; Omega 3 polyunsaturated fatty acid

Indexed keywords

DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; NUTRACEUTICAL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; RILUZOLE; VEGETABLE OIL;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG EFFICACY; FAT CONTENT; FAT INTAKE; HIGH RISK PATIENT; HUMAN; LIPID COMPOSITION; MORTALITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYNAPTOGENESIS;

EID: 84878001704     PISSN: 22134344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phanu.2012.12.002     Document Type: Review

References (56)

1. Menken M., Munsat T.L., Toole J.F. The global burden of disease study: implications for neurology. Archives of Neurology 2000, 57:418-420.
2. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., et al. Heart disease and stroke statistics - 2010 update: a report from the American heart association. Circulation 2010, 121:e46-e215.
3. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., et al. Heart disease and stroke statistics - 2008 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 2008, 117:e25-e146.
4. Di Carlo A., Launer L.J., Breteler M.M., Fratiglioni L., Lobo A., Martinez-Lage J., et al. Frequency of stroke in Europe: a collaborative study of population-based cohorts. Ilsa working group and the neurologic diseases in the elderly research group. Italian longitudinal study on aging. Neurology 2000, 54:S28-S33.
5. Spieler J.F., Lanoe J.L., Amarenco P. Costs of stroke care according to handicap levels and stroke subtypes. Cerebrovascular Diseases 2004, 17:134-142.
6. Kaur J., Zhao Z., Klein G.M., Lo E.H., Buchan A.M. The neurotoxicity of tissue plasminogen activator. Journal of Cerebral Blood Flow and Metabolism 2004, 24:945-963.
7. Hacke W., Kaste M., Bluhmki E., Brozman M., Davalos A., Guidetti D., et al. Thrombolysis with alteplase 3 to 4.5hours after acute ischemic stroke. New England Journal of Medicine 2008, 359:1317-1329.
8. O'Collins V.E., Macleod M.R., Donnan G.A., Horky L.L., van der Worp B.H., Howells D.W. 1026 experimental treatments in acute stroke. Annals of Neurology 2006, 59:467-477.
9. Moskowitz M.A., Lo E.H., Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010, 67:181-198.
10. Endres M., Dirnagl U. Ischemia and stroke. Advances in Experimental Medicine and Biology 2002, 513:455-473.
11. Moustafa R.R., Baron J.C. Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery. British Journal of Pharmacology 2008, 153(Suppl. 1):S44-S54.
12. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends in Neurosciences 1999, 22:391-397.
13. Naess H., Waje-Andreassen U., Nyland H. Risk factor burden predicts long-term mortality in young patients with arterial cerebral infarction. Acta Neurologica Scandinavica 2012, John Wiley & Sons A/S. 10.1111/j.1600-0404.2012.01681.x.
14. Allen C.L., Bayraktutan U. Risk factors for ischaemic stroke. International Journal of Stroke 2008, 3:105-116.
15. Blondeau N., Tauskela J.S. A new future in brain preconditioning based on nutraceuticals: a focus on a-linolenic omega-3 fatty acid for stroke protection. Innate tolerance in the CNS 2013, 133-163. Springer, New York. J.M. Gidday, M.A. Perez-Pinzon, J.H. Zhang (Eds.).
16. World Health Organization Who and fao joint consultation: fats and oils in human nutrition. Nutrition Reviews 1995, 53:202-205.
17. Holman R.T. Nutritional and metabolic interrelationships between fatty acids. Federation Proceedings 1964, 23:1062-1067.
18. Brenna J.T., Salem N., Sinclair A.J., Cunnane S.C. Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukotrienes and Essential Fatty Acids 2009, 80:85-91.
19. Emken E.A., Adlof R.O., Gulley R.M. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochimica et Biophysica Acta 1994, 1213:277-288.
20. Stanley J.C., Elsom R.L., Calder P.C., Griffin B.A., Harris W.S., Jebb S.A., et al. UK food standards agency workshop report: the effects of the dietary n-6:N-3 fatty acid ratio on cardiovascular health. British Journal of Nutrition 2007, 98:1305-1310.
21. de Lorgeril M., Salen P. Alpha-linolenic acid and coronary heart disease. Nutrition, Metabolism, and Cardiovascular Diseases 2004, 14:162-169.
22. Michaelsen K.F., Dewey K.G., Perez-Exposito A.B., Nurhasan M., Lauritzen L., Roos N. Food sources and intake of n-6 and n-3 fatty acids in low-income countries with emphasis on infants, young children (6-24 months), and pregnant and lactating women. Maternal & Child Nutrition 2011, 7(Suppl. 2):124-140.
23. Kalra E.K. Nutraceutical - definition and introduction. AAPS PharmSci 2003, 5:E25.
24. Hussein N., Ah-Sing E., Wilkinson P., Leach C., Griffin B.A., Millward D.J. Long-chain conversion of [13c]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. Journal of Lipid Research 2005, 46:269-280.
25. Pawlosky R.J., Hibbeln J.R., Novotny J.A., Salem N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. Journal of Lipid Research 2001, 42:1257-1265.
26. Barcelo-Coblijn G., Murphy E.J. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Progress in Lipid Research 2009, 48:355-374.
27. Burdge G.C., Calder P.C. Dietary alpha-linolenic acid and health-related outcomes: a metabolic perspective. Nutrition Research Reviews 2006, 19:26-52.
28. Wang C., Harris W.S., Chung M., Lichtenstein A.H., Balk E.M., Kupelnick B., et al. N-3 fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. American Journal of Clinical Nutrition 2006, 84:5-17.
29. Tinoco J. Dietary requirements and functions of alpha-linolenic acid in animals. Progress in Lipid Research 1982, 21:1-45.
30. King V.R., Huang W.L., Dyall S.C., Curran O.E., Priestley J.V., Michael-Titus A.T. Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. Journal of Neuroscience 2006, 26:4672-4680.
31. Dyall S.C., Michael-Titus A.T. Neurological benefits of omega-3 fatty acids. Neuromolecular Medicine 2008, 10:219-235.
32. Michael-Titus A.T. Omega-3 fatty acids and neurological injury. Prostaglandins Leukotrienes and Essential Fatty Acids 2007, 77:295-300.
33. Blondeau N., Widmann C., Lazdunski M., Heurteaux C. Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience 2002, 109:231-241.
34. Lauritzen I., Blondeau N., Heurteaux C., Widmann C., Romey G., Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO Journal 2000, 19:1784-1793.
35. Blondeau N., Nguemeni C., Debruyne D.N., Piens M., Wu X., Pan H., et al. Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for stroke. Neuropsychopharmacology 2009, 34:2548-2559.
36. Rabinovitz S., Mostofsky D.I., Yehuda S. Anticonvulsant efficiency, behavioral performance and cortisol levels: a comparison of carbamazepine (cbz) and a fatty acid compound (sr-3). Psychoneuroendocrinology 2004, 29:113-124.
37. Simopoulos A.P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Experimental Biology and Medicine (Maywood, NJ) 2008, 233:674-688.
38. Djousse L., Hunt S.C., Arnett D.K., Province M.A., Eckfeldt J.H., Ellison R.C. Dietary linolenic acid is inversely associated with plasma triacylglycerol: the national heart, lung, and blood institute family heart study. American Journal of Clinical Nutrition 2003, 78:1098-1102.
39. Simon J.A., Fong J., Bernert J.T., Browner W.S. Serum fatty acids and the risk of stroke. Stroke 1995, 26:778-782.
40. Heurteaux C., Guy N., Laigle C., Blondeau N., Duprat F., Mazzuca M., et al. Trek-1, a k+ channel involved in neuroprotection and general anesthesia. EMBO Journal 2004, 23:2684-2695.
41. Blondeau N., Petrault O., Manta S., Giordanengo V., Gounon P., Bordet R., et al. Polyunsaturated fatty acids are cerebral vasodilators via the trek-1 potassium channel. Circulation Research 2007, 101:176-184.
42. Garry A., Fromy B., Blondeau N., Henrion D., Brau F., Gounon P., et al. Altered acetylcholine, bradykinin and cutaneous pressure-induced vasodilation in mice lacking the trek1 potassium channel: the endothelial link. EMBO Reports 2007, 8:354-359.
43. Shimokawa T., Moriuchi A., Hori T., Saito M., Naito Y., Kabasawa H., et al. Effect of dietary alpha-linolenate/linoleate balance on mean survival time, incidence of stroke and blood pressure of spontaneously hypertensive rats. Life Sciences 1988, 43:2067-2075.
44. Heurteaux C., Laigle C., Blondeau N., Jarretou G., Lazdunski M. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 2006, 137:241-251.
45. Lang-Lazdunski L., Blondeau N., Jarretou G., Lazdunski M., Heurteaux C. Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. Journal of Vascular Surgery 2003, 38:564-575.
46. Blondeau N. Alpha-linolenic omega-3 fatty acid for stroke protection: from brain preconditioning paradigm to nutrition. OCL, Oléagineux, Corps Gras, Lipides 2011, 18:271-278.
47. Lim S.N., Huang W., Hall J.C., Michael-Titus A.T., Priestley J.V. Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid. Experimental Neurology 2012, 239C:13-27.
48. Lim S.N., Huang W., Hall J.C., Ward R.E., Priestley J.V., Michael-Titus A.T. The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats. Prostaglandins Leukotrienes and Essential Fatty Acids 2010, 83:193-201.
49. Heller A.R., Fischer S., Rossel T., Geiger S., Siegert G., Ragaller M., et al. Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery. British Journal of Nutrition 2002, 87(Suppl. 1):S95-S101.
50. Heller A.R., Rossler S., Litz R.J., Stehr S.N., Heller S.C., Koch R., et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine 2006, 34:972-979.
51. Blondeau N., Widmann C., Lazdunski M., Heurteaux C. Activation of the nuclear factor-kappab is a key event in brain tolerance. Journal of Neuroscience 2001, 21:4668-4677.
52. Bourre J.M., Dumont O., Pascal G., Durand G. Dietary alpha-linolenic acid at 1.3g/kg maintains maximal docosahexaenoic acid concentration in brain, heart and liver of adult rats. Journal of Nutrition 1993, 123:1313-1319.
53. Pudelkewicz C., Seufert J., Holman R.T. Requirements of the female rat for linoleic and linolenic acids. Journal of Nutrition 1968, 94:138-146.
54. Nguemeni C., Delplanque B., Rovere C., Simon-Rousseau N., Gandin C., Agnani G., et al. Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacological Research 2010, 61:226-233.
55. Gebauer S.K., Psota T.L., Harris W.S., Kris-Etherton P.M. N-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. American Journal of Clinical Nutrition 2006, 83:1526S-1535S.
56. Martin A. The "Apports nutritionnels conseilles (anc)" for the French population. Reproduction, Nutrition, Development 2001, 41:119-128.